Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study.

Daphne A M Dielemans; Karin Huizer; Marieke van der Pluijm; Andrea Thijssen; Nico J M van Beveren; Lieuwe de Haan

doi:10.1016/j.schres.2026.08.022

SCHEDA SCIENTIFICA2026Studio randomizzato

Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study.

Daphne A M Dielemans, Karin Huizer, Marieke van der Pluijm, Andrea Thijssen, Nico J M van Beveren, Lieuwe de Haan

Schizophrenia research · 2026

Psicologia clinica Psicopatologia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

AdolescentAdultFemaleHumansMaleYoung AdultAmisulprideAntipsychotic AgentsBiomarkersCytokinesInflammationPrincipal Component AnalysisProteomicsPsychotic DisordersSchizophreniaWeight GainAntipsychoticsPsychosisSide-effectsWeight gain

Come citare questo studio

Daphne A M Dielemans, Karin Huizer, Marieke van der Pluijm, Andrea Thijssen, Nico J M van Beveren, Lieuwe de Haan. (2026). Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study.. Schizophrenia research. DOI: 10.1016/j.schres.2026.08.022

Consulta la pubblicazione originale ↗